Literature DB >> 15541405

Pituitary-ovarian function following the standard levonorgestrel emergency contraceptive dose or a single 0.75-mg dose given on the days preceding ovulation.

H B Croxatto1, V Brache, M Pavez, L Cochon, M L Forcelledo, F Alvarez, R Massai, A Faundes, A M Salvatierra.   

Abstract

We assessed to what extent the standard dose of levonorgestrel (LNG), used for emergency contraception, or a single dose (half dose), given in the follicular phase, affects the ovulatory process during the ensuing 5-day period. Fifty-eight women were divided into three groups according to timing of treatment. Each woman contributed with three treatment cycles separated by resting cycles. All received placebo in one cycle, and standard or single dose in two other cycles, in a randomized order. The diameter of the dominant follicle determined the time of treatment. Each woman had the same diameter assigned for all her treatments. Diameters were grouped into 33 categories: 12-14, 15-17 or 18-20 mm. Follicular rupture failed to occur during the 5-day period in 44%, 50% and 36% of cycles with the standard, half dose and placebo, respectively. Ovulatory dysfunction, characterized by follicular rupture associated with absent, blunted or mistimed gonadotropin surge, occurred in 35%, 36% and 5% of standard, single dose or placebo cycles, respectively. In conclusion, LNG can disrupt the ovulatory process in 93% of cycles treated when the diameter of the dominant follicle is between 12 and 17 mm. It is highly probable that this mode of action fully accounts for the contraceptive efficacy as well as the failure rate of this method. The present data suggest that half the dose may be as effective as the standard dose.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15541405     DOI: 10.1016/j.contraception.2004.05.007

Source DB:  PubMed          Journal:  Contraception        ISSN: 0010-7824            Impact factor:   3.375


  34 in total

1.  Results from pooled Phase III studies of ulipristal acetate for emergency contraception.

Authors:  Caroline Moreau; James Trussell
Journal:  Contraception       Date:  2012-07-06       Impact factor: 3.375

2.  Pharmacokinetic study to compare the absorption and tolerability of two doses of levonorgestrel following single vaginal administration of levonorgestrel in Carraguard gel: a new formulation for "dual protection" contraception.

Authors:  Regine Sitruk-Ware; Vivian Brache; Robin Maguire; Horacio Croxatto; Narender Kumar; Sushma Kumar; Juan Carlos Montero; Ana Maria Salvatierra; David Phillips; Anibal Faundes
Journal:  Contraception       Date:  2007-04-18       Impact factor: 3.375

3.  College students' perceptions of emergency contraception provision.

Authors:  Anjel Vahratian; Divya A Patel; Kristen Wolff; Xiao Xu
Journal:  J Womens Health (Larchmt)       Date:  2008 Jan-Feb       Impact factor: 2.681

Review 4.  Pharmacokinetic and pharmacodynamic drug interactions between antiretrovirals and oral contraceptives.

Authors:  Victoria Tittle; Lauren Bull; Marta Boffito; Nneka Nwokolo
Journal:  Clin Pharmacokinet       Date:  2015-01       Impact factor: 6.447

Review 5.  Mechanism of action of levonorgestrel emergency contraception.

Authors:  Chris Kahlenborn; Rebecca Peck; Walter B Severs
Journal:  Linacre Q       Date:  2015-02

Review 6.  Ulipristal acetate: a review of its use in emergency contraception.

Authors:  Kate McKeage; Jamie D Croxtall
Journal:  Drugs       Date:  2011-05-07       Impact factor: 9.546

7.  UPA > LNG, but Not Good Enough.

Authors:  Kristina Gemzell-Danielsson; James Trussell
Journal:  Contraception       Date:  2013-08-21       Impact factor: 3.375

8.  From Kaua'i to Hawai'i Island: Interisland Differences in Emergency Contraceptive Pill Availability.

Authors:  Holly Bullock; Mary Tschann; Jennifer Elia; Bliss Kaneshiro; Jennifer Salcedo
Journal:  Hawaii J Med Public Health       Date:  2017-07

9.  Impact of the prostaglandin synthase-2 inhibitor celecoxib on ovulation and luteal events in women.

Authors:  Alison B Edelman; Jeffrey T Jensen; Carmen Doom; Jon D Hennebold
Journal:  Contraception       Date:  2012-08-16       Impact factor: 3.375

10.  Emergency contraception: potential role of ulipristal acetate.

Authors:  Kristina Gemzell-Danielsson; Chun-Xia Meng
Journal:  Int J Womens Health       Date:  2010-08-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.